A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
Titel:
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
Auteur:
Rabe, Klaus F. Martinez, Fernando J. Ferguson, Gary T. Wang, Chen Singh, Dave Wedzicha, Jadwiga A. Trivedi, Roopa St Rose, Earl Ballal, Shaila McLaren, Julie Darken, Patrick Reisner, Colin Dorinsky, Paul